Advice
On 31 July 2014, the European Commission issued a decision to withdraw the marketing authorisation for Doribax, following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH’s decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons. Please see link to European Medicines Agency statement.

Medicine details

Medicine name:
doripenem (Doribax)
SMC ID:
529/09
Indication:
Complicated intra-abdominal infections
Pharmaceutical company
Janssen-Cilag Ltd
BNF chapter
Infections
Submission type
Full submission
Status
Withdrawn
Date advice published:
09 February 2009